These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 9227787
1. Scintimammography using Tc-99m tetrofosmin. Lind P, Umschaden HW, Forsthuber E, Oman J, Kerschbaumer K, Gallowitsch HJ, Mikosch P, Kresnik E, Molnar M, Gomez I. Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787 [Abstract] [Full Text] [Related]
2. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions. Lind P, Gallowitsch HJ, Kogler D, Kresnik E, Mikosch P, Gomez I. Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502 [Abstract] [Full Text] [Related]
3. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Fenlon HM, Phelan N, Tierney S, Gorey T, Ennis JT. Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430 [Abstract] [Full Text] [Related]
4. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer. Schillaci O, Scopinaro F, Danieli R, Picardi V, Tavolaro R, Cannas P, Colella AC. Anticancer Res; 1997 Jan; 17(3B):1623-6. PubMed ID: 9179206 [Abstract] [Full Text] [Related]
5. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Spanu A, Dettori G, Nuvoli S, Porcu A, Falchi A, Cottu P, Solinas ME, Scanu AM, Chessa F, Madeddu G. Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916 [Abstract] [Full Text] [Related]
6. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Fenlon HM, Phelan NC, O'Sullivan P, Tierney S, Gorey T, Ennis JT. Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988 [Abstract] [Full Text] [Related]
7. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. Gommans GM, van der Zant FM, van Dongen A, Boer RO, Teule GJ, de Waard JW. Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524 [Abstract] [Full Text] [Related]
8. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection. Spanu A, Tanda F, Dettori G, Manca A, Chessa F, Porcu A, Falchi A, Nuvoli S, Madeddu G. Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872 [Abstract] [Full Text] [Related]
9. [Clinical value of (99m)Tc-tetrofosmin imaging and ultrasonography in diagnosis of breast cancer: a comparative study]. Chen Q, An XY, Liang H. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):140-1. PubMed ID: 18227047 [Abstract] [Full Text] [Related]
10. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Cwikla JB, Buscombe JR, Kelleher SM, Parbhoo SP, Thakrar DS, Hinton J, Deery AR, Crow J, Hilson AJ. Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043 [Abstract] [Full Text] [Related]
11. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts. Yang MD, Sun SS, Kao CH, Lin CC, Lee CC. Cancer Invest; 2002 Apr; 20(4):518-23. PubMed ID: 12094547 [Abstract] [Full Text] [Related]
12. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement. Jaukovic LDj, Ajdinovic BZ, Jankovic ZD, Strbac M. Nucl Med Rev Cent East Eur; 2006 Apr; 9(1):30-6. PubMed ID: 16791801 [Abstract] [Full Text] [Related]
13. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results]. Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt YE. Rev Esp Med Nucl; 1998 Apr; 17(5):338-50. PubMed ID: 9812008 [Abstract] [Full Text] [Related]
14. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology. Ortapamuk H, Ozmen MM, Ibis S, Naldöken S, Aksoy F. Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548 [Abstract] [Full Text] [Related]
15. The usefulness of 99mTc-tetrofosmin SPECT scintimammography in the detection of small size primary breast carcinomas. Spanu A, Schillaci O, Meloni GB, Porcu A, Cottu P, Nuvoli S, Falchi A, Chessa F, Solinas ME, Madeddu G. Int J Oncol; 2002 Oct; 21(4):831-40. PubMed ID: 12239623 [Abstract] [Full Text] [Related]
16. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H, Tiling R, Pechmann M, Kindermann G, Kress K, Moser R, Tatsch K, Hahn K, Pfluger T, Assemi C. Zentralbl Gynakol; 1997 Oct; 119(1):6-11. PubMed ID: 9050197 [Abstract] [Full Text] [Related]
17. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss JF, Klein SR. Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855 [Abstract] [Full Text] [Related]
18. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742 [Abstract] [Full Text] [Related]
19. Chest wall recurrence of breast cancer demonstrated on 99mTc-MIBI scintimammography. Usmani S, Niaz K, Maseeh-Uz-Zaman, Niyaz K, Khan HA, Habib S, Kamal S. Nucl Med Commun; 2007 Nov; 28(11):842-6. PubMed ID: 17901766 [Abstract] [Full Text] [Related]
20. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Helbich TH, Becherer A, Trattnig S, Leitha T, Kelkar P, Seifert M, Gnant M, Staudenherz A, Rudas M, Wolf G, Mostbeck GH. Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068 [Abstract] [Full Text] [Related] Page: [Next] [New Search]